Home > LTE Scientific Ltd > Advancing Genetic Research with LTE Scientific Autoclave at Oxford Science Park

Advancing Genetic Research with LTE Scientific Autoclave at Oxford Science Park

LTE Scientific Ltd News and PR from LTE Scientific Ltd - Published 12 June 2024 Nucleome Therapeutics, a prominent UK biotech company, is at the forefront of decoding the dark matter of the human genome to develop innovative precision medicines.
Their mission focuses on the non-coding regions of DNA, unlocking new potential for drug discovery and development for autoimmune diseases such as multiple sclerosis, lupus, and rheumatoid arthritis.

To view the full news article click the pdf below:
Related Downloadable pdf's
The user function is great, and the cycle times are much better compared to previous equipment I've used

Other announcements from LTE Scientific Ltd